Maternal serum PAPP-A and free β-hCG at 12, 22 and 32 weeks' gestation in screening for pre-eclampsia.
about
First-Trimester and Second-Trimester Maternal Serum Biomarkers as Predictors of Placental Abruption.Integrated Proteomic and Metabolomic prediction of Term Preeclampsia.Lower placental growth factor and higher free β-hCG and PAPP-A levels in the fetal circulation of near-term pregnancies complicated with severe preeclampsia.
P2860
Maternal serum PAPP-A and free β-hCG at 12, 22 and 32 weeks' gestation in screening for pre-eclampsia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Maternal serum PAPP-A and free ...... n screening for pre-eclampsia.
@en
Maternal serum PAPP-A and free ...... n screening for pre-eclampsia.
@nl
type
label
Maternal serum PAPP-A and free ...... n screening for pre-eclampsia.
@en
Maternal serum PAPP-A and free ...... n screening for pre-eclampsia.
@nl
prefLabel
Maternal serum PAPP-A and free ...... n screening for pre-eclampsia.
@en
Maternal serum PAPP-A and free ...... n screening for pre-eclampsia.
@nl
P2093
P2860
P356
P1476
Maternal serum PAPP-A and free ...... n screening for pre-eclampsia.
@en
P2093
K H Nicolaides
M Pellegrino
P2860
P304
P356
10.1002/UOG.15849
P577
2016-01-04T00:00:00Z